Answers are grounded in this paper and cite their sources.
Immunotherapy improves health and work productivity in the Czech Republic, suggesting significant societal benefits.
Expanding the use of anti-PD-(L)1 agents for early-stage cancer treatment in the Czech Republic is expected to reduce events/recurrences and metastatic treatments while also extending survival, quality-of-life, and productive work years, supporting the clinical and societal value of earlier use of innovative immunotherapies.
No takes yet. Share an insight, caveat, or question.
Blezer et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: